Antibody responses to DNA in normal immunity and aberrant immunity

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 1, 1998, Pages 1-6

  Pisetsky, David S ^a,b,c  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; HUMAN; IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031883095     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.1.1-6.1998     Document Type: Review

References (52)

1. Aarden, L. A., F. Lakmaker, and E. R. De Groot. 1976. Immunology of DNA. IV. Quantitative aspects of the Farr assay. J. Immunol. Methods 11:153 -163.
2. Bunyard, M. P., and D. S. Pisetsky. 1994. Characterization of antibodies to bacterial double-stranded DNA in the sera of normal human subjects. Int. Arch. Allergy Immunol. 105:122-127.
3. dispersen, G. F., and E. W. Voss, Jr. 1983. Specificity of anti-DNA antibodies in SLE. I. Definition and gross specificity of antibody populations in human SLE plasma. Mol. Immunol. 20:573-580.
4. Casperson, G. F., and E. W. Voss, Jr. 1983. Specificity of anti-DNA antibodies in SLE-II. Relative contribution of backbone, secondary structure and nucleotide sequence to DNA binding. Mol. Immunol. 20:581-588.
5. Emlen, W., D. S. Pisetsky, and R. P. Taylor. 1986. Antibodies to DNA: a perspective. Arthritis Rheum. 29:1417-1426.
6. Foster, M. H., B. Cizman, and M. P. Madaio. 1993. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties. mechanisms of immune deposition, and genetic origins. Lab. Invest. 69:494-507.
7. Fredriksen, K., A. Skogsholm, T. Flaegstad, T. Traavik, and O. P. Rekvig. 1993. Antibodies to dsDNA are produced during primary BK virus infection in man, indicating that anti-dsDNA antibodies may be related Io virus replication in vivo. Scand. J. Immunol. 38:401-406.
8. Gilkeson, G. S., A. M. M. Pippen, and D. S. Pisetsky. 1995. Induction of cross-reactive nati-dsDNA antibodies in preautoimmune NZB/NZW mice by immunisation with bacterial DNA. J. Clin. Invest. 95:1398-1402.
9. 11 CDR3 arginines. J. Immunol. 151:1353-1364.
10. Gilkeson, G. S., J. P. Grudier, D. G. Karounos, and D. S. Pisetsky. 1989. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol. 142:1482-1486.
11. Gilkeson, G. S., J. P. Grudier, D. G. Karounos, and D. S. Pisetsky. 1989. The antibody response of normal mice to immunization with single-stranded DNA of various species origin. Clin. Immunol. Immunopathol. 51:362-371.
12. Hartmann, G., A. Krug, K. Waller-Fontaine, and S. Endres. 1996 Oligodeoxynuclcotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioatc modification and reversal by heparin. Mol. Mcd. 2:429-438.
13. Hergersberg, M. 1991. Biological aspects of cytosine methylation in cukaryotic cells. Experientia 47:1171-1185.
14. Izui, S., N. M. Zaldivar, I. Scher, and P.-H. Lambert. 1977. Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice. I. Anti-DNA induction by LPS without significant release of DNA in circulating blood. J. Immunol. 119:2151-2156.
15. Karounos, U. G., J. P. Grudier, and D. S. Pisetsky. 1988. Spontaneous expression of antibodies to DNA of various species origin in sera of normal subjects and patients with systemic lupus erythematosus. J. Immunol. 140: 451-455.
16. Kataoka, T., S. Yamamoto, T. Yamamoto, E. Kuramoto, Y. Kimura, O. Yano, and T. Tokunaga. 1992. Antitumor activity of synthetic oligonueleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG. Jpn. J. Cancer Res. 83:244-247.
17. Klinman, D. M., A.-K. Yi. S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interletikin 12, and interferon γ. Proc. Nall. Acad. Sci. USA 93:2879-2883.
18. Klinman, D. M., G. Yamshchikov, and Y. Ishigatsubo. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. lmmunol. 158:3635-3639.
19. Kredich, N. M., J. S. Skyler, and L. J. Foote. 1973. Antibodies to native UNA in systemic lupus erythematosus. Arch, lntern. Med. 131:639 644.
20. Krieg, A. M. 1995. CpG DNA: a pathogenic factor in systemic lupus crythemalosus? J. Clin, lmmunol. 15:281-292.
21. Krieg, A. M., A.-K. Yi, S. Maison, T. J. Waldschmidt. G. A. Bishop. R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
22. Maduio, M. P., S. Hodder. R. S. Schwartz, and B. D. Stollar. 1934. Rcsponsivencss of autoimmune and normal mice to nucleic acid antigens J lmmunol. 132:872-876.
23. Messina. J. P., G. S. Gilkeson, and D. S. Piselsky. 1991. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. lmmunol 147-1759-1764.
24. Pardoll, D. M., and A. M. Beekerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165 -169.
25. Pisetsky, D. S. 1992. Anti-DNA antibodies in systemic lupus crythematosus Rheum. Dis. Clin. N. Am. 18:437-454.
26. Pisetsky, D. S. 1990. Immune activation by bacterial DNA: a new genelic code. Immunity 5:303-310.
27. Pisclsky, D. S. 1996. The immunologic properties of DNA. J. lmmunol. 156:421-423.
28. Piselsky, D. S., and C. Reich. 1993. Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides. Mol. Biol. Rep. 18:217-221.
29. Pisetsky, D. S., and D. M. Drayton. 1997. Deficient expression of antibodies specific for bacterial DNA by patients with systemic lupus erythematosus. Proc. Assoc. Am. Phys. 109:237-244.
30. Piselsky, D. S., G. G. Gilkeson, and E. W. St. Clair. 1997. Systemic lupus erythematosus. Diagnosis and treatment. Med. Clin. N. Am. 81:1 13-128.
31. Radie, M. Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. lmmunol. 12:487-520.
32. Rohertsun, C. R., and D. S. Pisetsky. 1992. Specificity analysis of antibodies to single-stranded micrococcal DNA in the sera of normal human subjects and patients with systemic lupus erythematosus. Clin. Exp. Rheum. 10:589-594.
33. Rohertson, C. R., C. S. Gilkeson, M. M. Ward, and D. S. Pisetsky. 1992 Patterns of heavy and light chain utilization in the antibody response to single-stranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus. Clin. lmmunol. lmmunopathol. 62:25-32.
34. Sabbaga, J., O. G. Pankewycz, V. Lufft, R. S. Schwartz, and M. P. Madaio. 1990. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J. Autoimmun. 3:215-235.
35. Sato, Y., M. Roman, H. Tight', D. Lee, M. Corr, M.-D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunoslimulatary DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
36. Schwartz, D. A., T. J. Quinn, P. S. Thorne, S. Sayeed, A.-K. Yi, and A. M. Krieg. 1997. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100:68-73.
37. Sparwasser, T., T. Miethkc, G. Lipford, K. Borschert, H. Hacker, K. Ileeg, and H. Wagner. 1997. Bacterial DNA causes septic shock. Nature 386:336-337.
38. Stein, C. A., and Y.-C. Cheng. 1993. Antisense oligonueleotides as therapeutic agents-is the bullet really magical? Science 261:1004-1012.
39. Stollar, B. D. 1994. Molecular analysis nf anti-DNA antibodies. FASEB J. 8:337-342.
40. Stollar, D., L. Levine, and J. Marmur. 1962. Antibodies to denatured deoxyribonucleic acid in lupus erythematosus serum. II. Characterization of antibodies in several sera. Bioch. Biophys. Acta 61:7-18.
41. Tan, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. lmmunol. 44:93-151.
42. Terinaat, R.-M., K. J. M. Assmann, H. B. P. M. Dijkman, F. V. Gompel, R. J. T. Smeenk, and J. H. M. Berden. 1992. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 42:1363-1371.
43. Tokunaga, T., H. Yamamoto, S. Shimada, H. Abe, T. Fukuda, Y. Fujisawa, Y. Furulani, O. Yanu, T. Kataoka, T. Sudo, N. Makiguchi, and T. Suganuina. 1984. Antitumor activity of deoxyribonucleic acid fraction from Mycobacteriun bovis BCG. I. Isolation, physicochcmical characterization, and antitumor activity. J. Natl. Cancer Inst. 72:955-962.
44. Uhlmann. E., and A. Peyman. 1990. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90:544-584.
45. Ulmer. J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Feigner. V. J. Dwarki. S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Pern, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Hcterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
46. Valeric, R. D., K. A. Bernstein, F,. Varghese, and J. B. Lefkowith. 1995. Murine lupus glomerulotropic monoclonal antibodies exhibit differing specificities but bind via a common mechanism. J. lmmunol. 155:2258-2268.
47. Vlahakus, D., M. H. Foster, A. A. Ucci, K. J. Barrett, S. K. Datla, and M. P. Madaio. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2:1345-1354.
48. Wu, Z.-Q., D. Drayton, and D. S. Pisetsky. 1997. Specificity and immunochemical properties of antibodies to bacterial DNA in sera of normal human subjects and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 109:27-31.
49. Yamamoto, S., E. Kuramoto, S. Shimada, and T. Tokunaga. 1988. In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79:866-873.
50. Yamamoto, S., T. Yamamoto, S. Shimada, E. Kuramoto, O. Yano, T. Kataoka, and T. Tokunaga. 1992. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36:983-997.
51. Yamamoto, S., T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T. Tokunaga. 1992. Unique palindromic sequences in synthetic oligonucleotidcs are required to induce INF and augment INF-mediated natural killer activity. J. Immunol. 148:4072-4076.
52. Yamamoto, T., S. Yamamoto, T. Kataoka, and T. Tokunaga. 1994 Lipofectin of synthetic uligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol. Immunol. 38:831-836.